// App-Quantinova.ai

OP079 : Morphine is associated with delayed platelet inhibition in patients with STEMI undergoing primary PCI with prasugrel and bivalirudin

Researchers

Presenter

  • Kandan S.R

Principal Investigators

  • Mumford A.D

  • Scott L.J

  • Mundell S

  • Butler M

  • Strange J.W

  • Rogers C.A

  • Reeves B.C

  • Baumbach A

  • Johnson T.W

Medical Centers

  • University of Bristol, Bristol, United Kingdom

  • Bristol Heart Institute, Bristol, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Venous thrombosis

  • Twin-reversed arterial perfusion

Biomarkers

  • Triiodothyronine receptor auxiliary protein

Drug/Treatment

  • Bivalirudin

  • Prasugrel

  • Morphine

  • D-morphine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved